← brief for 2026-08-13 · Slowing decline

Haikunshenxi capsule alleviates renal fibrosis in chronic kidney disease via modulation of indoxyl Sulfate–Aryl hydrocarbon receptor signaling

Paper D Peer reviewed Preclinical

Key takeaways

This study in mice found that a capsule treatment could reduce kidney the aryl hydrocarbon receptor signaling pathway.

Who did this work

Ping Li (Nanjing University of Chinese Medicine) · Chong Chen (Nanjing University of Chinese Medicine) · Bangjie Zuo (Nanjing University of Chinese Medicine) · Jing Zhao (Nanjing University of Chinese Medicine) · Hao Tang (Nanjing University of Chinese Medicine) · B Chen (Nanjing University of Chinese Medicine) · Lin Qiao (Nanjing University of Chinese Medicine) · Wei Sun (Nanjing University of Chinese Medicine) · Si Sun (Nanjing University of Chinese Medicine)

Source

Paper · OpenAlex, CKD works · 2026-08-11
https://doi.org/10.3389/fphar.2026.1819011